Starpharma Holdings Health Care
Biotech Cancer Healthcare Pharmaceuticals

$0.310 0.030 (10.71%)

High $0.31	Low $0.29	Trades 582	Turnover $291,413	Volume 965,700
30 June 2023 at 4:10pm

Market Cap (11-Sep) $336,323,712 (436th)	Close (30-Jun) $0.310 0 (0%)	Volume (30-Jun) 965,700	Shortsold (8-Sep) 184,704 (0.04%) (506th)
52w High $0.83	52w Low $0.120	P/E 312.50	EPS -0.02
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 1+

Short Interest

ASIC data, 8 Sep 2026

% Shorted

0.04% 0.00

vs 0.03% prior report

Most Shorted Rank

506th

of 694 shorted ASX stocks

Peak Short

5.92%

Sep 2013

Days to Cover

0.1

at 50d avg vol

View full short position history →

	Subject
	SPL SPL Ann: Clinical Trial Update
	1 (current) 2 3
	SPL SPL Ann: Life Sciences Investor Forum Presentation
	SPL SPL Ann: Starpharma to present at Life Sciences Investor Forum
	SPL SPL Ann: AZD0466 Clinical Data Presented by AstraZeneca EHA Congress
	SPL SPL Ann: Starpharma CEO to retire in 2024
	SPL SPL Ann: VIRALEZE Nasal Spray Approved in Malaysia
	SPL SPL Ann: Application for quotation of securities - SPL
	SPL SPL Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	SPL SPL Ann: HER2-targeted DEP SN38 ADC outperforms in HER2 cancer model
	SPL SPL Ann: AZD0466 active in small cell lung cancer patient models
	SPL SPL Ann: DEP cabazitaxel Ph 2 trial completes enrolment & treatment
	SPL SPL Ann: Commencement of CFO and Company Secretary
	SPL SPL Ann: Starpharma presents at ASX Small and Mid-Cap Conference
	SPL SPL Ann: Application for quotation of securities - SPL
	SPL SPL Ann: CFO and Company Secretary Appointment
	SPL SPL Ann: Interim Report and Half-Year Financial Results
	SPL SPL Ann: Dr Russell Basser appointed as director and Appendix 3X
	SPL SPL Ann: Change in substantial holding
	SPL SPL Ann: Change in substantial holding
	SPL SPL Ann: Application for quotation of securities - SPL
	SPL SPL Ann: Appointment of Company Secretary
	SPL SPL Ann: Dr Russell Basser appointed as non-executive director
	SPL SPL Ann: Quarterly Activities Report & Appendix 4C
	SPL SPL Ann: Response to ASX Query Letters
	SPL SPL Ann: Starpharma receives $7.1M R&D tax incentive refund
	SPL SPL Ann: Resignation of CFO / Company Secretary
	SPL SPL Ann: VIRALEZE Nasal Spray Registered in Indonesia
	SPL SPL Ann: Positive AZD0466 clinical data presented by AstraZeneca
	SPL SPL Ann: VIRALEZE Post-Market Clinical Study in COVID-19 Patients
	SPL SPL Ann: Change in Director's Interest Notice - J Fairley
	SPL SPL Ann: Notification regarding unquoted securities - SPL
	SPL SPL Ann: Retirement of non-executive Director
	SPL SPL Ann: AGM Results
	SPL SPL Ann: AGM Chairman address and CEO presentation
	SPL SPL Ann: VIRALEZE launched in Hong Kong and Macau
	SPL SPL Ann: Starpharma to present at Bell Potter Healthcare Conference
	SPL SPL Ann: Change in Director's Interest Notice - R Thomas
	SPL SPL Ann: Change in Director's Interest Notice - J Fairley
	SPL SPL Ann: Notice of Annual General Meeting/Proxy Form
	SPL SPL Ann: Application for quotation of securities - SPL
	SPL SPL Ann: Notification regarding unquoted securities - SPL
	SPL SPL Ann: Quarterly Activities Report & Appendix 4C
	SPL SPL Ann: VIRALEZE distribution agreement for Hong Kong and Macau
	SPL SPL Ann: Change in substantial holding
	SPL SPL Ann: Change in Director's Interest Notice - J Fairley
	SPL SPL Ann: Notification of cessation of securities - SPL
	SPL SPL Ann: Board Renewal
	SPL SPL Ann: 2022 Annual General Meeting Date
	SPL SPL Ann: Starpharma to present at Life Sciences Investor Forum
	SPL SPL Ann: Change in substantial holding

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

End of Day Prices

Date	Close	Volume	Change
11-Sep	$0.71	3,163,667	-0.08 (10.19%)
10-Sep	$0.79	1,842,055	-0.03 (3.09%)
09-Sep	$0.81	2,866,972	0.00 (0.00%)
08-Sep	$0.81	2,108,483	+0.02 (1.89%)
07-Sep	$0.80	2,968,622	+0.04 (5.30%)
04-Sep	$0.76	1,175,866	+0.02 (2.72%)
03-Sep	$0.74	1,055,477	+0.02 (2.08%)
02-Sep	$0.72	773,320	0.00 (0.00%)
01-Sep	$0.72	895,344	0.00 (0.00%)
31-Aug	$0.72	2,835,328	+0.01 (0.70%)
28-Aug	$0.72	175,657	0.00 (0.00%)
27-Aug	$0.72	2,968,864	-0.01 (1.38%)
26-Aug	$0.73	869,024	-0.01 (0.68%)
25-Aug	$0.73	1,013,712	+0.01 (0.69%)
24-Aug	$0.73	2,549,841	-0.01 (0.68%)
6 up, 5 down, and 4 flat days

Starpharma Holdings Health Care Biotech Cancer Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Starpharma Holdings Health Care
Biotech Cancer Healthcare Pharmaceuticals